Literature DB >> 6489401

Altered interrelationship of dopamine, prolactin, thyrotropin and thyroid hormone in schizophrenic patients.

M L Rao, G Gross, G Huber.   

Abstract

Increased dopaminergic activity has been postulated to be one of the main causes of schizophrenia. To evaluate this hypothesis further, the interrelation between dopamine, prolactin, thyrotropin (TSH) and L-thyroxine was studied by determining their concentrations in the serum of ten acutely ill schizophrenic patients exhibiting distinct stages of process activity and ten healthy subjects. The level of dopamine was elevated in the sera of schizophrenic patients, whereas the levels of prolactin, TSH and L-thyroxine were decreased. On the basis of these results we hypothesize that 1. increased dopaminergic activity affects pituitary secretory function, and 2. decreased beta-adrenergic activity may be a consequence of decreased thyroid hormone concentration in plasma.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6489401     DOI: 10.1007/bf00432877

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Neurol Sci        ISSN: 0175-758X


  29 in total

1.  beta-Adrenergic receptors in rat heart: effects of thyroidectomy.

Authors:  S P Banerjee; L S Kung
Journal:  Eur J Pharmacol       Date:  1977-05-15       Impact factor: 4.432

2.  [Clinical-electroencephalographic correlation studies in schizophrenics].

Authors:  G Huber; H Penin
Journal:  Fortschr Neurol Psychiatr Grenzgeb       Date:  1968-11

3.  [The concept of substrate-close basic symptoms and its significance for the theory and therapy of schizophrenic diseases].

Authors:  G Huber
Journal:  Nervenarzt       Date:  1983-01       Impact factor: 1.214

Review 4.  A hypothesis of thyroid-catecholamine-receptor interaction. Its relevance to affective illness.

Authors:  P C Whybrow; A J Prange
Journal:  Arch Gen Psychiatry       Date:  1981-01

5.  Behavioral and endocrine responses of schizophrenic patients to TRH (protirelin).

Authors:  A J Prange; P T Loosen; I C Wilson; H Y Meltzer; V S Fang
Journal:  Arch Gen Psychiatry       Date:  1979-09

6.  Effects of dopamine infusion on pituitary hormone secretion in humans.

Authors:  H Leblanc; G C Lachelin; S Abu-Fadil; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1976-09       Impact factor: 5.958

7.  The dopamine hypothesis: an overview of studies with schizophrenic patients.

Authors:  J L Haracz
Journal:  Schizophr Bull       Date:  1982       Impact factor: 9.306

8.  Novel double-isotope technique for enzymatic assay of catecholamines, permitting high precision, sensitivity and plasma sample capacity.

Authors:  M J Brown; D A Jenner
Journal:  Clin Sci (Lond)       Date:  1981-11       Impact factor: 6.124

9.  Serum dopamine-beta-hydroxylase activity in schizophrenia.

Authors:  H Y Meltzer; S J Nasr; C Tong
Journal:  Biol Psychiatry       Date:  1980-10       Impact factor: 13.382

10.  Endocrine and behavioral changes in depression after thyrotropin-releasing hormone (TRH). Alteration by pretreatment with thyroid hormones.

Authors:  P T Loosen; I C Wilson; A J Prange
Journal:  J Affect Disord       Date:  1980-12       Impact factor: 4.839

View more
  6 in total

1.  Modification of the radioreceptor assay technique for estimation of serum neuroleptic drug levels leads to improved precision and sensitivity.

Authors:  M L Rao
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Serum amino acid profiles and dopamine in schizophrenic patients and healthy subjects: Window to the brain?

Authors:  M L Rao; B Strebel; G Gross; G Huber
Journal:  Amino Acids       Date:  1992-02       Impact factor: 3.520

3.  Revisiting thyroid hormones in schizophrenia.

Authors:  Nadine Correia Santos; Patrício Costa; Dina Ruano; António Macedo; Maria João Soares; José Valente; Ana Telma Pereira; Maria Helena Azevedo; Joana Almeida Palha
Journal:  J Thyroid Res       Date:  2012-03-26

4.  Redefining the Cut-Off Ranges for TSH Based on the Clinical Picture, Results of Neuroimaging and Laboratory Tests in Unsupervised Cluster Analysis as Individualized Diagnosis of Early Schizophrenia.

Authors:  Natalia Śmierciak; Marta Szwajca; Tadeusz J Popiela; Amira Bryll; Paulina Karcz; Paulina Donicz; Aleksander Turek; Wirginia Krzyściak; Maciej Pilecki
Journal:  J Pers Med       Date:  2022-02-09

Review 5.  Prolactin and psychopathology in schizophrenia: a literature review and reappraisal.

Authors:  Ravi Philip Rajkumar
Journal:  Schizophr Res Treatment       Date:  2014-03-27

6.  Level of thyroid-stimulating hormone (TSH) in patients with acute schizophrenia, unipolar depression or bipolar disorder.

Authors:  Adam Wysokiński; Iwona Kłoszewska
Journal:  Neurochem Res       Date:  2014-04-11       Impact factor: 3.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.